Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00797849 · ClinicalTrials.gov registry record · NA

Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees

A NA study of Phantom Limb Pain, sponsored by Southern California Institute for Research and Education.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT00797849 is a NA study of Phantom Limb Pain that has completed, run by Southern California Institute for Research and Education. The registered enrollment target is 57 participants, below the 118-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00797849, a NA study of Phantom Limb Pain, has completed, sponsored by Southern California Institute for Research and Education.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to determine if the group using Farabloc shows a greater reduction in pain levels than the group not using Farabloc at 6-week, 12-week and 1-month post treatment follow-ups.

Conditions Studied

Interventions

  • DEVICE Farabloc Limb Cover
  • DEVICE Sham Limb Cover

Study Locations (1)

California

  • VA Long Beach Healthcare System - Long Beach

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2008-11
Est. Completion 2011-11
Phase NA

What the Registry Record Tells You About NCT00797849

The ClinicalTrials.gov registry entry for NCT00797849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (52% lower). The listed sponsor is Southern California Institute for Research and Education, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 2 interventions - of which Farabloc Limb Cover is the first listed.

NCT00797849 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00797849 about?

NCT00797849 is a clinical study titled "Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees". The primary purpose of this study is to determine if the group using Farabloc shows a greater reduction in pain levels than the group not using Farabloc at 6-week, 12-week and 1-month post treatment follow-ups.

What is the current status of trial NCT00797849?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2008-11. Estimated completion is 2011-11.

What conditions does trial NCT00797849 study?

This clinical trial studies the following conditions: Phantom Limb Pain.

What interventions are being tested in trial NCT00797849?

The interventions under investigation include: Farabloc Limb Cover (DEVICE), Sham Limb Cover (DEVICE).

Who is sponsoring clinical trial NCT00797849?

This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00797849 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.